CompletedEUCTR 2008-006947-38
A study of D-cycloserine-augmented exposure therapy in adolescents with OCD
This study is completed in the United Kingdom. It is testing D-cycloserine-augmented exposure therapy for OCD.
In United KingdomOCDOther
Study directory
Back to overviewMental health studies with practical context.
Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
OngoingEUCTR 2016-000118-31
A phase II double-blinded study of intravenous immunoglobulins and rituximab in people with antibody-associated psychosis (SINAPPS2)
This study is ongoing in the United Kingdom. It focuses on Schizophrenia.
In United KingdomSchizophreniaOther
OngoingEUCTR 2016-001637-27
Effectiveness of lithium and quetiapine augmentation in treatment-resistant depression
This study is ongoing in the United Kingdom. It is testing lithium and quetiapine augmentation for treatment-resistant depression.
In United KingdomDepressionOther
CompletedEUCTR 2008-000908-91
A 6-week, multicentre, rater-blinded parallelgroup study comparing Quetiapine extended release monotherapy and augmentation with Lithium augmentation in people with Treatm...
This study is completed in the United Kingdom, in Belgium, in Germany, .... It focuses on Depression.
In United KingdomDepressionOther
TerminatedEUCTR 2005-004482-41
A double blind, double-dummy, parallel group study to compare the efficacy and tolerability of morphine sulphate prolonged release capsules and methadone oral solution in once per day a...
This study was terminated in the United Kingdom. It focuses on Addiction.
In United KingdomAddictionOther
CompletedEUCTR 2011-002362-21
A active-controlled, flexible dose study evaluating the effects of Lu AA21004 versus agomelatine in adult patients suffering from major depressive disorder...
This study is completed in the United Kingdom, in Belgium, in Sweden, .... It focuses on depression.
In United KingdomDepressionOther
OngoingEUCTR 2020-000469-18
IP2018 for Depression
This study is ongoing in the United Kingdom. It is testing IP2018 for Depression.
In United KingdomDepressionOther
CompletedEUCTR 2014-002639-32
A study of Vitamin D supplementation compared to placebo in people presenting with their First Episode of psychosis (DFEND) Neuroprotect...
This study is completed in the United Kingdom. It focuses on Schizophrenia.
In United KingdomSchizophreniaOther
OngoingEUCTR 2015-000323-86
A parallel group, double blind, placebo controlled, add on study to investigate whether the lithium mimetic, ebselen, can reduce symptoms of hypomania and mania in bipolar pati...
This study is ongoing in the United Kingdom. It focuses on manic episodes in bipolarity.
In United KingdomBipolarityOther
OngoingEUCTR 2018-003573-97
Randomised, placebo controlled trial of psilocybin for treatment-resistant depression
This study is ongoing in the United Kingdom. It is testing randomised, placebo controlled trial of psilocybin for treatment-resistant depression.
In United KingdomDepressionOther
OngoingEUCTR 2018-001884-21
A study of the antidepressant efficacy of a novel CNS-penetrant P2X7 receptor antagonist, JNJ-54175446, in people with major depressive disorder, an inc...
This study is ongoing in the United Kingdom. It focuses on depression.
In United KingdomDepressionOther
TerminatedEUCTR 2013-004903-37
LURASIDONE for Bipolarity
This study was terminated in France, in the United Kingdom, in Italy, .... It is testing LURASIDONE for Bipolarity.
In United KingdomBipolarity, DepressionOther
Public registry coverage is progressing
HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.